clinical trials bpc 157 Integrative Peptides BPC-157: complete guide to oral peptide supplements BPC-157 FDA Approval Status: Is
Description
Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PLD-148, PL-1415), wound healing, and vascular blockage
Injections are appropriate only for vegans with confirmed deficiency or documented absorption problems.
However, oral bioavailability is much lower than injectable, meaning the doses are higher (3 mg, 7 mg, and 14 mg tablets compared to the 0.25 to 2.4 mg injectable range)
For extended storage, aliquot and freeze at minus 20 degrees Celsius
Worldwide Shipping We ship across the EU & internationally tracked to your door
